YouTube Facebook LinkedIn Google+ Twitter Xingrss  

May-June Contents


Feature

A Social Approach to Patient Recruitment
Better use of Web 2.0 sites like Twitter, Facebook and PatientsLikeMe could be a boon for enrollment.

Special Report: Bio-IT World Conference & Expo 2010

The Complexities of Data Management 
Genotypes, Phenotypes and Personal Health
Technologies and Standards 
Rewriting the Textbook of Evolution 

Four Secrets to Success 
Christoph Westphal dishes on aging and pharmageddon.

Harnessing (and Securing) Meaningful Data 
John Halamka talks about the future of health data.

Clouds and More Clouds in Seattle 
AWS's Singh talks passions: science and the cloud.

2010 Best of Show Awards 

Up Front

GET Celebrates Pioneers
Genome pioneers included guest of honor, Jim Watson.

Life in the Fast Life
Mark Stevenson takes a multigenerational approach.

Ion Torrent Announces Sequencer Winners
Next-gen company gives away two $50,000 machines in contest

2010 New Technology Survey
The Bush Doctrine 
Survey reflects spending on new technologies.

Life Sciences R&D Ascending to the Cloud
Insights | Outlook
Cloud computing survey shows increasing interest.

A Total Knockout?
Myriad’s loss means gene patents advance to next level.

Briefs 

Clinical Trials

Integrating EDC at DFCI
EDC saves one million paper forms.

Safety Watch
Quanticate selects Oracle Argus Safety for pharmacovigilance database.

Clinical Trials and EHRs 
EHRs save money, improve care.

Trends in Global Life Sciences Economic Development

Life Sciences Economic Development Trends 2010 

The Changing Face of Bioscience Real Estate 

Ningbo Lures Biotech South of Shanghai

Computational Biology

A Bioinformatics Chief and a Gentleman
Genentech’s senior director of bioinformatics and computational biology.

IT/Workflow

Cloud Convergence
DNAnexus debuts cloud computing resource for next-gen sequence data.

The Data Side of Accelerated Biocomputing
Getting speed for data analysis.

Computational Development

A New Rap for Chemistry
Computational chemistry can predict the fragments worth making.

Rhythm and Blues: The Case for Allosteric Modulators
Switzerland’s Addex Pharmaceuticals rides optimism after drug setback.

Domainex Expands Breast Cancer Drug Deal with ICR
Company IDs ‘Lipinski-enhanced’ compounds.

In Every Issue

Ash, Clouds, and the 2010 Bio-IT World Expo
First Base | A volcano didn’t slow down the biggest Expo yet.
BY KEVIN DAVIES

Thermo’s Bold Bet
The Russell Transcript | The big name in LIMS takes on small labs.
BY JOHN RUSSELL

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.